Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system

  1. Fabrice Jean-Pierre  Is a corresponding author
  2. Thomas H Hampton
  3. Daniel Schultz
  4. Deborah A Hogan
  5. Marie-Christine Groleau
  6. Eric Déziel
  7. George A O'Toole  Is a corresponding author
  1. Dartmouth College, United States
  2. Institut National de la Recherche Scientifique, Canada

Abstract

Interspecies interactions can drive the emergence of unexpected microbial phenotypes that are not observed when studying monocultures. The cystic fibrosis (CF) lung consists of a complex environment where microbes, living as polymicrobial biofilm-like communities, are associated with negative clinical outcomes for persons with CF (pwCF). However, the current lack of in vitro models integrating the microbial diversity observed in the CF airway hampers our understanding of why polymicrobial communities are recalcitrant to therapy in this disease. Here, integrating computational approaches informed by clinical data, we built a mixed community of clinical relevance to the CF lung composed of Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus sanguinis and Prevotella melaninogenica. We developed and validated this model biofilm community with multiple isolates of these four genera. When challenged with tobramycin, a front-line antimicrobial used to treat pwCF, the microorganisms in the polymicrobial community show altered sensitivity to this antibiotic compared to monospecies biofilms. We observed that wild-type P. aeruginosa is sensitized to tobramycin in a mixed community versus monoculture, and this observation holds across a range of community relative abundances. We also report that LasR loss-of-function, a variant frequently detected in the CF airway, drives tolerance of P. aeruginosa to tobramycin specifically in the mixed community. Our data suggest that the molecular basis of this community-specific recalcitrance to tobramycin for the P. aeruginosa LasR mutant is increased production of phenazines. Our work support the importance of studying a clinically-relevant model polymicrobial biofilms to understand community-specific traits relevant to infections.

Data availability

Figure 1 - figure supplement 3 & Source Data 1 contains the numerical data used to generate the figure.Figure 1 - figure supplement 4 & Source Data 2 contains numerical data used to generate the figure.Source Code 1 contains the script used to generate Figure 1, Figure 1 - figure supplement 1 and Figure 1 - figure supplement 4.Source Code 2 contains the script used to generate the modeling data presented Figure 1 - figure supplement 1.

The following previously published data sets were used

Article and author information

Author details

  1. Fabrice Jean-Pierre

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    For correspondence
    fabricejean-pierre@dartmouth.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Thomas H Hampton

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Daniel Schultz

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Deborah A Hogan

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Marie-Christine Groleau

    Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Eric Déziel

    Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. George A O'Toole

    Department of Microbiology and Immunology, Dartmouth College, Hanover, United States
    For correspondence
    georgeo@dartmouth.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2861-4392

Funding

Cystic Fibrosis Foundation (JEAN21F0)

  • Fabrice Jean-Pierre

National Institutes of Health (R01 AI155424)

  • George A O'Toole

Canadian Institutes of Health Research (MOP-142466)

  • Eric Déziel

National Institutes of Health (5 P20 GM130454)

  • Daniel Schultz

Cystic Fibrosis Foundation (HOGAN19G0)

  • Deborah A Hogan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Vaughn S Cooper, University of Pittsburgh, United States

Version history

  1. Preprint posted: June 24, 2022 (view preprint)
  2. Received: July 4, 2022
  3. Accepted: January 19, 2023
  4. Accepted Manuscript published: January 20, 2023 (version 1)
  5. Accepted Manuscript updated: January 23, 2023 (version 2)
  6. Version of Record published: February 3, 2023 (version 3)

Copyright

© 2023, Jean-Pierre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,549
    Page views
  • 347
    Downloads
  • 12
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fabrice Jean-Pierre
  2. Thomas H Hampton
  3. Daniel Schultz
  4. Deborah A Hogan
  5. Marie-Christine Groleau
  6. Eric Déziel
  7. George A O'Toole
(2023)
Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system
eLife 12:e81604.
https://doi.org/10.7554/eLife.81604

Share this article

https://doi.org/10.7554/eLife.81604

Further reading

    1. Microbiology and Infectious Disease
    Chiara Andolina, Wouter Graumans ... Teun Bousema
    Research Article

    It is currently unknown whether all Plasmodium falciparum-infected mosquitoes are equally infectious. We assessed sporogonic development using cultured gametocytes in the Netherlands and naturally circulating strains in Burkina Faso. We quantified the number of sporozoites expelled into artificial skin in relation to intact oocysts, ruptured oocysts, and residual salivary gland sporozoites. In laboratory conditions, higher total sporozoite burden was associated with shorter duration of sporogony (p<0.001). Overall, 53% (116/216) of infected Anopheles stephensi mosquitoes expelled sporozoites into artificial skin with a median of 136 expelled sporozoites (interquartile range [IQR], 34–501). There was a strong positive correlation between ruptured oocyst number and salivary gland sporozoite load (ρ = 0.8; p<0.0001) and a weaker positive correlation between salivary gland sporozoite load and number of sporozoites expelled (ρ = 0.35; p=0.0002). In Burkina Faso, Anopheles coluzzii mosquitoes were infected by natural gametocyte carriers. Among salivary gland sporozoite positive mosquitoes, 89% (33/37) expelled sporozoites with a median of 1035 expelled sporozoites (IQR, 171–2969). Again, we observed a strong correlation between ruptured oocyst number and salivary gland sporozoite load (ρ = 0.9; p<0.0001) and a positive correlation between salivary gland sporozoite load and the number of sporozoites expelled (ρ = 0.7; p<0.0001). Several mosquitoes expelled multiple parasite clones during probing. Whilst sporozoite expelling was regularly observed from mosquitoes with low infection burdens, our findings indicate that mosquito infection burden is positively associated with the number of expelled sporozoites. Future work is required to determine the direct implications of these findings for transmission potential.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Veronica Teresa Ober, George Boniface Githure ... Michael Boshart
    Research Article

    Cyclic nucleotide binding domains (CNB) confer allosteric regulation by cAMP or cGMP to many signaling proteins, including PKA and PKG. PKA of phylogenetically distant Trypanosoma is the first exception as it is cyclic nucleotide-independent and responsive to nucleoside analogues (Bachmaier et al., 2019). Here, we show that natural nucleosides inosine, guanosine and adenosine are nanomolar affinity CNB ligands and activators of PKA orthologs of the important tropical pathogens Trypanosoma brucei, Trypanosoma cruzi, and Leishmania. The sequence and structural determinants of binding affinity, -specificity and kinase activation of PKAR were established by structure-activity relationship (SAR) analysis, co-crystal structures and mutagenesis. Substitution of two to three amino acids in the binding sites is sufficient for conversion of CNB domains from nucleoside to cyclic nucleotide specificity. In addition, a trypanosomatid-specific C-terminal helix (αD) is required for high affinity binding to CNB-B. The αD helix functions as a lid of the binding site that shields ligands from solvent. Selectivity of guanosine for CNB-B and of adenosine for CNB-A results in synergistic kinase activation at low nanomolar concentration. PKA pulldown from rapid lysis establishes guanosine as the predominant ligand in vivo in T. brucei bloodstream forms, whereas guanosine and adenosine seem to synergize in the procyclic developmental stage in the insect vector. We discuss the versatile use of CNB domains in evolution and recruitment of PKA for novel nucleoside-mediated signaling.